Form 4: SANUWAVE Director Ian Miller Granted Stock Options

SANUWAVE Health Director Ian D. Miller was granted 1,733 stock options, fully vested at grant, with an exercise price of $29.84.

Summary

• Ian D. Miller, a Director of SANUWAVE Health, Inc. (SNVW), was granted stock options.
• The grant involved 1,733 derivative securities, specifically stock options (right to buy).
• The exercise price for these options is $29.84 per share.
• The options were fully vested at the grant date.
• The options become exercisable on December 31, 2025, and expire on December 31, 2030.
• Each option represents the right to acquire one share of SANUWAVE Health Common Stock.
• Following this transaction, Ian D. Miller beneficially owns 1,733 derivative securities directly.

Sentiment

Score: 6

Explanation: The grant of stock options to a director is a standard form of executive compensation, aligning management interests with shareholder value. The options are fully vested at grant, which is a positive for the recipient.

Positives

• The grant of 1,733 stock options to Director Ian D. Miller aligns his interests with shareholders.
• Options were fully vested at the grant date, providing immediate ownership rights upon exercisability.

Future Outlook

No specific forward-looking statements or guidance are provided in this insider transaction report.

Industry Context

This report details an individual insider transaction, which is a routine part of executive compensation and does not directly relate to broader industry trends or competitive analysis.

Related Party Transactions

• Grant of 1,733 stock options to Director Ian D. Miller as part of his compensation package.

Stakeholder Impact

• Shareholders: Potential alignment of director's interests with shareholder value through equity ownership.
• Director (Ian D. Miller): Receives equity compensation.

Key Dates

Keywords

SANUWAVE Health, SNVW, Stock Options, Director Compensation, Insider Transaction, Form 4, Equity Grant